Evidence map›Paper›PMID 39839312›Full record

ArticleOncoscience2025

Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database.

Aaron Samuels, Ahmad Badeghiesh, Haitham Baghlaf, Michael H Dahan

Abstract read
In one paragraph

Article in Oncoscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aaron SamuelsMcGill Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
Ahmad BadeghieshDepartment of Obstetrics and Gynecology, King Abdulaziz University, Rabigh, Saudi Arabia.
Haitham BaghlafDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Tabuk, Tabuk, Saudi Arabia.
Michael H DahanMcGill Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceCervical cancer is the fourth most common cancer among women globally and a significant cause of cancer-related deaths. Understanding the impact of cervical cancer diagnosed during pregnancy on maternal, delivery, and neonatal outcomes is crucial for improving clinical management and outcomes for affected women and their children.

objectiveTo determine the effects of cervical cancer diagnosed during pregnancy on maternal, delivery, and neonatal outcomes using a population based, American database.

designThis study is a retrospective analysis of the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (HCUP-NIS) database. The study period spans between 2004-2014, and the analysis was conducted in 2023.

settingThe study used the HCUP-NIS database, which includes data from hospital stays across the United States, covering 48 states and the District of Columbia.

participantsThe study included all women who delivered a child or had a maternal death from 2004-2014, with pregnancies at 24 weeks or above. The population was comprised of 9,096,788 pregnant women, including 222 diagnosed with cervical cancer prior to delivery. EXPOSURES: The exposure was a diagnosis of cervical cancer during pregnancy, identified using International Classification of Diseases 9th Revision codes 180.0, 180.1, 180.8, and 180.9. MAIN OUTCOMES AND MEASURES: Primary outcomes included maternal, delivery, and neonatal complications including preterm delivery, cesarean section, hysterectomy, blood transfusion, deep venous thrombosis, pulmonary embolism, congenital anomalies, intrauterine fetal demise, and small-for-gestational-age neonates. Logistic regression analyses were conducted to evaluate the association between cervical cancer diagnosis and these outcomes, adjusting for potential confounding factors.

resultsWomen with cervical cancer were older (25.2% ≥35 years vs. 14.7%, CONCLUSIONS AND RELEVANCE: Cervical cancer during pregnancy is associated with significant maternal and delivery risks, however, neonatal outcomes are largely unaffected. These findings highlight the need for a multidisciplinary approach in managing pregnant cervical cancer patients, involving oncological, obstetrical, and neonatal care specialists.

Indexed as

cervical cancerdelivery outcomesfetal outcomesmaternal outcomespregnancy

Identifiers

PMID39839312
PMCPMC11748763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.